ABACAVIR-LAMIVUDINE 600-300 MG

Abacavir and lamivudine
$1.3206per EA

Strength

600; 300 mg/1; mg/1

Manufacturer

Cipla USA Inc.

NDC

69097036202

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA091144

On Market Since

3/28/2017

Price History

1W

0.0%

1M

+4.6%

3M

-3.4%

6M

-13.0%

1Y

-22.6%

3Y

-29.3%

5Y

-46.8%

All

-93.5%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.